drugset / Trial / NCT06368921
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
To Evaluate the safety and tolerability of single and multiple intratumoral injections of recombinant oncolytic virus M1 (VRT106) in patients with locally advanced/metastatic solid tumors.
Timeline
- Start
- 2024-06-19
- Primary completion
- 2026-09
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VRT106 | Unknown | — | Other |